Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality

Lupus. 2009 Apr;18(5):383-6. doi: 10.1177/0961203308101435.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aspirin / therapeutic use
  • Azetidines / therapeutic use
  • Clinical Trials as Topic
  • Coronary Artery Disease / complications*
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / physiopathology
  • Drug Therapy, Combination
  • Ezetimibe
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Myocardial Infarction / prevention & control*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Risk

Substances

  • Azetidines
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Ezetimibe
  • Aspirin